(Q44582775)

4 December 2017

A novel approach of prophylaxis to HBV recurrence after liver transplantation (English)

1 reference

4 December 2017

liver transplantation

1 reference

Tao Pan

1

1 reference

4 December 2017

Ming Cai

2

1 reference

4 December 2017

Li Tang

3

1 reference

4 December 2017

Li Qiao Zhou

4

1 reference

4 December 2017

Bin Jian Li

5

1 reference

4 December 2017

Tong Zhu

6

1 reference

4 December 2017

Hong Zhou Li

7

1 reference

4 December 2017

Shu Yuan Li

8

1 reference

4 December 2017

Xiao Xiao

9

1 reference

4 December 2017

Zhi Shui Chen

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

21 October 2008

1 reference

4 December 2017

1 reference

4 December 2017

382

1 reference

4 December 2017

1

1 reference

4 December 2017

1-9

1 reference

Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Hepatitis B epidemiology in Asia, the Middle East and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Current concepts for prophylaxis and treatment of hepatitis B virus reinfection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

7 January 2021

Liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Yeast surface display for directed evolution of protein expression, affinity, and stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Management of hepatitis B in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Small animal model systems for studying hepatitis B virus replication and pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Identification of PDGFR as a receptor for AAV-5 transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Hepatitis B immune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Global status of hepatitis B immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

The complete mitochondrial genome of Tupaia belangeri and the phylogenetic affiliation of scandentia to other eutherian orders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

HBsAg and HBcAg in the livers of asymptomatic hepatitis B antigen carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.06.024

1 reference

4 December 2017

1 reference